BALDWIN BROTHERS LLC/MA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$18,385
-4.5%
2150.0%0.00%
-50.0%
Q3 2023$19,260
+5.2%
2150.0%0.00%0.0%
Q2 2023$18,305
-4.2%
215
-6.9%
0.00%0.0%
Q1 2023$19,115
+5.2%
2310.0%0.00%0.0%
Q4 2022$18,168
-17.4%
231
-23.3%
0.00%
-33.3%
Q3 2022$22,000
+10.0%
3010.0%0.00%0.0%
Q2 2022$20,000
-20.0%
301
-23.8%
0.00%0.0%
Q1 2022$25,000
+19.0%
3950.0%0.00%
+50.0%
Q4 2021$21,000
-25.0%
3950.0%0.00%
-33.3%
Q3 2021$28,000
+7.7%
3950.0%0.00%0.0%
Q2 2021$26,000
-49.0%
395
-13.2%
0.00%
-50.0%
Q1 2021$51,000
-16.4%
455
-11.0%
0.01%
-25.0%
Q4 2020$61,000
+35.6%
5110.0%0.01%
+33.3%
Q3 2020$45,000
-31.8%
511
-30.5%
0.01%
-40.0%
Q2 2020$66,000
-33.3%
735
-25.8%
0.01%
-41.2%
Q1 2020$99,000
-13.2%
9900.0%0.02%
+6.2%
Q4 2019$114,000
-10.9%
990
-2.7%
0.02%
-15.8%
Q3 2019$128,000
-77.8%
1,017
-78.8%
0.02%
-77.6%
Q2 2019$576,000
+11.6%
4,789
-18.8%
0.08%
+10.4%
Q1 2019$516,000
-56.7%
5,899
-50.4%
0.08%
-61.5%
Q4 2018$1,191,000
-12.7%
11,9030.0%0.20%
+4.7%
Q3 2018$1,364,000
+19.4%
11,903
-6.5%
0.19%
+7.9%
Q2 2018$1,142,0000.0%12,736
-18.4%
0.18%
-4.3%
Q1 2018$1,142,000
+9.8%
15,610
-12.8%
0.18%
+14.2%
Q4 2017$1,040,000
+29.5%
17,9050.0%0.16%
+25.6%
Q3 2017$803,000
+13.6%
17,9050.0%0.13%
+13.2%
Q2 2017$707,000
-2.6%
17,9050.0%0.11%
-5.0%
Q1 2017$726,000
+0.8%
17,9050.0%0.12%
-7.7%
Q4 2016$720,000
+11.1%
17,9050.0%0.13%
+10.2%
Q3 2016$648,000
+548.0%
17,905
+475.9%
0.12%
+594.1%
Q3 2015$100,000
-27.0%
3,109
-6.0%
0.02%
-15.0%
Q2 2015$137,000
-8.1%
3,3090.0%0.02%
-9.1%
Q1 2015$149,000
-13.9%
3,309
-19.4%
0.02%
-21.4%
Q4 2013$173,000
+45.4%
4,106
+38.1%
0.03%
+27.3%
Q3 2013$119,0002,9740.02%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders